Literature DB >> 13065694

Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin; para-aminosalicylic acid in pulmonary tuberculosis therapy. IV. Report on forty-week observations on 583 patients with streptomycin susceptible infections.

F W MOUNT, B E JENKINS, S H FEREBEE.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID ISOMERS/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1953        PMID： 13065694     DOI： 10.1164/art.1953.68.2.264

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  7 in total

1.  Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro.

Authors:  M L COHN; G MIDDLEBROOK; W F RUSSELL
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  COMBINED chemotherapy in tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1955-02-19

3.  VARIOUS combinations of isoniazid with streptomycin or with P.A.S. in the treatment of pulmonary tuberculosis; seventh report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee.

Authors: 
Journal:  Br Med J       Date:  1955-02-19

4.  Antimicrobial therapy of pulmonary tuberculosis.

Authors:  W McDermott
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

5.  THE PREVENTION AND TREATMENT OF ISONIAZID TOXICITY IN THE THERAPY OF PULMONARY TUBERCULOSIS. 2. AN ASSESSMENT OF THE PROPHYLACTIC EFFECT OF PYRIDOXINE IN LOW DOSAGE.

Authors:  L A ZILBER; Z L BAJDAKOVA; A N GARDASJAN; N V KONOVALOV; T L BUNINA; E M BARABADZE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

6.  Peripheral neuritis due to isoniazid.

Authors:  S DEVADATTA; P R GANGADHARAM; R H ANDREWS; W FOX; C V RAMAKRISHNAN; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

7.  A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India.

Authors: 
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.